BioNexus Gene Lab
BGLC
#9929
Rank
$5.39 M
Marketcap
$0.30
Share price
5.04%
Change (1 day)
-23.08%
Change (1 year)

Revenue for BioNexus Gene Lab (BGLC)

Revenue in 2024 (TTM): $9.18 Million USD

According to BioNexus Gene Lab's latest financial reports the company's current revenue (TTM ) is $9.18 Million USD. In 2023 the company made a revenue of $9.77 Million USD a decrease over the revenue in the year 2022 that were of $10.92 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for BioNexus Gene Lab from 2019 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) $9.18 M-6.01%
2023 $9.77 M-10.6%
2022 $10.92 M-18.21%
2021 $13.36 M-28.25%
2020 $18.62 M14570.54%
2019 $0.12 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA